PACS Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 13, 2025 to Discuss Your Rights - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against PACS Group, Inc. - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. ("PACS" or the "Company") (NYSE:PACS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Levi & Korsinsky Reminds PACS Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 13, 2025 - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
PACS Group, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 13, 2025 to Discuss Your Rights - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies Shareholders of PACS Group, Inc.(PACS) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Notifies PACS Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
PACS Group, Inc. Investors: January 13, 2025 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
SAN FRANCISCO, CA / ACCESSWIRE / December 5, 2024 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in PACS Group, Inc. ("PACS" or the "Company") (NYSE:PACS) who purchased or otherwise acquired PACS common stock between April 11, 2024, and November 5, 2024, inclusive (the "Class Period"), including investors who purchased PACS common stock pursuant and/or traceable to the registration statements issued in connection with PACS's April 11, 2024 initial public offering ("IPO"), and/or the Company's September 6, 2024 secondary public offering ("SPO"), to contact us immediately regarding a pending securities class action against PACS. The deadline to apply to be lead plaintiff is January 13, 2025.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 13, 2025 in PACS Group, Inc. Lawsuit - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
PACS CLASS UPDATE: The January 13 Investor Deadline in the PACS Group Securities Fraud Class Action is Approaching - Contact BFA Law if You have Losses
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting Click Here
PACS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PACS Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / December 5, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired PACS Group: (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 11, 2024 initial public offering ("IPO" or the "Offering"); and/or (b) securities between April 11, 2024 and November 5, 2024, both dates inclusive ("the Class Period"); and/or (c) common stock pursuant, or traceable, or both, to the SPO Materials issued in connection with PACS' September 2024 secondary public offering (the "SPO").
PACS Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 13, 2025 to Discuss Your Rights - PACS
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your PACS Group, Inc. (NYSE:PACS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PACS Group
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group To Contact Him Directly To Discuss Their Options NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered losses exceeding $50,000 in PACS Group between (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 11, 2024 initial public offering ("IPO" or the "Offering"); and/or (b) all persons and entities that purchased or otherwise acquired PACS common stock pursuant, or traceable, or both, to the SPO Materials (as defined herein) issued in connection with PACS' September 2024 secondary public offering (the "SPO"); and/or (c) securities between April 11, 2024 and November 5, 2024 inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PACS Group, Inc. ("PACS Group" or the "Company") (NYSE: PACS) and reminds investors of the January 13, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
